hydroxychloroquine has been researched along with Dyspnea in 24 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Dyspnea: Difficult or labored breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recurrences of COVID-19 were observed in a patient with long-term usage of hydroxychloroquine, leflunomide, and glucocorticoids due to her 30-year history of rheumatoid arthritis (RA)." | 5.05 | A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab. ( Cai, S; Dong, L; Li, M; Sun, W, 2020) |
| "Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered." | 2.72 | Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. ( Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M, 2021) |
| "Dyspnea is associated with a more severe infection." | 1.62 | Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. ( Algaba, A; Bermejo, F; Bonillo, D; Garza, D; Guerra, I; Jiménez, L; Mar Aller, M; Molina Esteban, LM, 2021) |
| "Moreover, PTSD in patients with COVID-19 is not associated with the increased risk of CFS." | 1.62 | Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. ( Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L, 2021) |
| "Key words: Coronavirus disease 2019 (COVID-19), Meningoencephalitis, Pneumonia." | 1.56 | A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19). ( Khan, MA, 2020) |
| "The progression from DLE to systemic lupus erythematosus has been reported in up to 28% of patients." | 1.39 | Pulmonary hemorrhage in a patient initially presenting with discoid lupus. ( Jiménez-Encarnación, E; Vilá, S; Vilá-Rivera, K, 2013) |
| "While pleuropulmonary involvement in systemic lupus erythematosus (SLE) is a common occurrence, shrinking lung syndrome (SLS) is a rare complication of SLE, particularly in children." | 1.39 | Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12-year-old girl. ( Berner, R; Geiger, J; Heinzmann, A; Hufnagel, M; Meinicke, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 15 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, S | 1 |
| Hoch, V | 1 |
| Gilbert, T | 1 |
| Nelson, S | 1 |
| Sheetz, K | 1 |
| Ghaferi, A | 1 |
| Wakeam, E | 1 |
| Co, I | 1 |
| Spezzani, V | 1 |
| Piunno, A | 1 |
| Iselin, HU | 1 |
| Aminian, A | 1 |
| Kermansaravi, M | 1 |
| Azizi, S | 1 |
| Alibeigi, P | 1 |
| Safamanesh, S | 1 |
| Mousavimaleki, A | 1 |
| Rezaei, MT | 1 |
| Faridi, M | 1 |
| Mokhber, S | 1 |
| Pazouki, A | 1 |
| Safari, S | 1 |
| Rahmanzade, R | 1 |
| Rahmanzadeh, R | 1 |
| Hashemian, SM | 1 |
| Bozzalla Cassione, E | 1 |
| Zanframundo, G | 1 |
| Biglia, A | 1 |
| Codullo, V | 1 |
| Montecucco, C | 1 |
| Cavagna, L | 1 |
| Cai, S | 1 |
| Sun, W | 1 |
| Li, M | 1 |
| Dong, L | 1 |
| Firouzabadi, FD | 1 |
| Firouzabadi, MD | 1 |
| Ghalehbaghi, B | 1 |
| Jahandideh, H | 1 |
| Roomiani, M | 1 |
| Goudarzi, S | 1 |
| Khan, MA | 2 |
| Choi, NH | 1 |
| Silver, ES | 1 |
| Fremed, M | 1 |
| Liberman, L | 1 |
| Guerra, I | 1 |
| Algaba, A | 1 |
| Jiménez, L | 1 |
| Mar Aller, M | 1 |
| Garza, D | 1 |
| Bonillo, D | 1 |
| Molina Esteban, LM | 1 |
| Bermejo, F | 1 |
| Zurita, MF | 1 |
| Iglesias Arreaga, A | 1 |
| Luzuriaga Chavez, AA | 1 |
| Zurita, L | 1 |
| Mondal, R | 1 |
| Ganguly, U | 1 |
| Deb, S | 1 |
| Shome, G | 1 |
| Pramanik, S | 1 |
| Bandyopadhyay, D | 1 |
| Lahiri, D | 1 |
| Ortiz Molina, E | 1 |
| Hernandez Pailos, R | 1 |
| Pola Guillen, M | 1 |
| Pascual Pedreno, A | 1 |
| Rodriguez Rodriguez, E | 1 |
| Hernandez Martinez, A | 1 |
| Emamikhah, M | 1 |
| Babadi, M | 1 |
| Mehrabani, M | 1 |
| Jalili, M | 1 |
| Pouranian, M | 1 |
| Daraie, P | 1 |
| Mohaghegh, F | 1 |
| Aghavali, S | 1 |
| Zaribafian, M | 1 |
| Rohani, M | 1 |
| Simani, L | 1 |
| Ramezani, M | 1 |
| Darazam, IA | 1 |
| Sagharichi, M | 1 |
| Aalipour, MA | 1 |
| Ghorbani, F | 1 |
| Pakdaman, H | 1 |
| Lazovic, B | 1 |
| Zlatkovic-Svenda, M | 1 |
| Jasarovic, D | 1 |
| Stevanovic, D | 1 |
| Lee, E | 1 |
| Seo, JH | 1 |
| Kim, HY | 1 |
| Yu, J | 1 |
| Jhang, WK | 1 |
| Park, SJ | 1 |
| Kwon, JW | 1 |
| Kim, BJ | 1 |
| Do, KH | 1 |
| Cho, YA | 1 |
| Kim, SA | 1 |
| Jang, SJ | 1 |
| Hong, SJ | 1 |
| Vilá-Rivera, K | 1 |
| Jiménez-Encarnación, E | 1 |
| Vilá, S | 1 |
| Hirshoren, N | 1 |
| Eliashar, R | 1 |
| Weinberger, JM | 1 |
| Efthimiou, P | 1 |
| Kukar, M | 1 |
| Hersh, A | 1 |
| Abbasi, S | 1 |
| Tarter, L | 1 |
| Farzaneh-Far, R | 1 |
| Farzaneh-Far, A | 1 |
| Rabach, I | 1 |
| Poli, F | 1 |
| Zennaro, F | 1 |
| Germani, C | 1 |
| Ventura, A | 1 |
| Barbi, E | 1 |
| Meinicke, H | 1 |
| Heinzmann, A | 1 |
| Geiger, J | 1 |
| Berner, R | 1 |
| Hufnagel, M | 1 |
| Al-Raqum, HA | 1 |
| Uppal, SS | 1 |
| Al-Mutairy, M | 1 |
| Kumari, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Incidence of COVID-19 Test Conversion in Post-surgical Patients[NCT04392323] | 111 participants (Actual) | Interventional | 2020-05-13 | Completed | |||
| Efficacy and Security of the Magnesium and Vitamin D Combination as Adjuvant Treatment of Post-COVID Syndrome. A Randomised Double-blind Clinical Trial[NCT05630339] | 150 participants (Actual) | Interventional | 2022-01-30 | Completed | |||
| Neuropsychological Sequelae as a Risk Factor for Long COVID-19 Fatigue[NCT05323318] | 200 participants (Anticipated) | Observational | 2022-04-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for hydroxychloroquine and Dyspnea
| Article | Year |
|---|---|
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antirheumatic Agents; Antiviral Agents; Arthritis, R | 2020 |
Meningoencephalitis associated with COVID-19: a systematic review.
Topics: Adult; Aged; Antiviral Agents; Azithromycin; Confusion; Cough; COVID-19; COVID-19 Drug Treatment; Dy | 2021 |
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; | 2021 |
21 other studies available for hydroxychloroquine and Dyspnea
| Article | Year |
|---|---|
A 44-Year-Old Woman with Dyspnea and Hemoptysis in the Setting of Remote Bariatric Surgery.
Topics: Adult; Antibodies, Antinuclear; Bariatric Surgery; Dyspnea; Female; Hemoptysis; Humans; Hydroxychlor | 2022 |
Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.
Topics: Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Breast Neoplasms; Cobicistat; Coronavirus | 2020 |
Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak.
Topics: Adult; Anti-Retroviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Dyspnea; Fa | 2020 |
Respiratory Distress in Postanesthesia Care Unit: First Presentation of Coronavirus Disease 2019 in a 17-Year-Old Girl: A Case Report.
Topics: Adolescent; Airway Extubation; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus; Coronav | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Labora | 2020 |
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diar | 2020 |
A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19).
Topics: Anti-Bacterial Agents; Anticoagulants; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus; | 2020 |
COVID-19 reveals Brugada pattern in an adolescent patient.
Topics: Antiviral Agents; Brugada Syndrome; C-Reactive Protein; Chest Pain; Consanguinity; Cough; COVID-19; | 2020 |
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
Topics: Adult; Biological Therapy; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Dyspnea; Fema | 2021 |
SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
Topics: Adult; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Dyspnea; | 2020 |
COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
Topics: Adult; Anosmia; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; C-Reactive Protein; Cesarea | 2020 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations | 2021 |
Systemic Lupus Erythematosus Presenting as Acute Lupus Pneumonitis.
Topics: Acute Disease; Aged; Chest Pain; Diagnosis, Differential; Dyspnea; Emergencies; Female; Fever; Human | 2018 |
Toxic inhalational injury-associated interstitial lung disease in children.
Topics: APACHE; Bronchi; Child, Preschool; Cough; Cyclophosphamide; Disinfectants; Dyspnea; Enzyme Inhibitor | 2013 |
Pulmonary hemorrhage in a patient initially presenting with discoid lupus.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Bronchopneumonia; Diagnostic Errors; Disease Progression; Dysp | 2013 |
Hydroxychloroquine for subglottic stenosis: a novel therapy in the battle for air.
Topics: Accidental Falls; Administration, Oral; Aged, 80 and over; Antimalarials; Dose-Response Relationship | 2010 |
Rituximab and lupus interstitial lung disease: friend or foe?
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Drug Therapy, Combination; Dysp | 2011 |
Hydroxychloroquine: a treatable cause of cardiomyopathy.
Topics: Antirheumatic Agents; Biopsy; Cardiomyopathies; Coronary Angiography; Diagnosis, Differential; Dyspn | 2012 |
Is treatment with hydroxychloroquine effective in surfactant protein C deficiency?
Topics: Disease Progression; Diseases in Twins; Dyspnea; Failure to Thrive; Humans; Hydroxychloroquine; Infa | 2013 |
Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12-year-old girl.
Topics: Chest Pain; Child; Cyclophosphamide; Diaphragm; Dyspnea; Female; Humans; Hydroxychloroquine; Immunos | 2013 |
Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti.
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Female; Glucocorticoids; Humans; | 2006 |